Tranexamic acid for spontaneous intracerebral hemorrhage: a randomized controlled pilot trial (ISRCTN50867461) [PDF]
Background: Spontaneous intracerebral hemorrhage (ICH) can be devastating, particularly if hematoma expansion (HE) occurs. Tranexamic acid (TA), an antifibrinolytic drug, significantly reduced mortality in bleeding patients after trauma in the large ...
Al-Shahi Salman+32 more
core +2 more sources
The Jehovah’s Witness obstetric patient – a literature review
The patient’s right to refuse blood transfusion must be honoured in case of its clear expression. Some special pharmacologic and/or surgical procedures can be useful in a Jehovah Witness (JW) parturient.
Aleksandra Rajewska+5 more
doaj +1 more source
An analysis of mechanisms underlying the antifibrinolytic properties of radiographic contrast agents. [PDF]
Peter Farrehi+2 more
openalex +1 more source
Peri- and Postpartum Management of Patients With Factor XI Deficiency
Factor XI (FXI) deficiency is an uncommon autosomal disorder with variable bleeding phenotype, making peripartum management challenging. We describe our experience in pregnant women with FXI deficiency and identify strategies to minimize the use of ...
Gloria F. Gerber MD+4 more
doaj +1 more source
MP13-06 CAN INTRAVESICAL ADMINISTRATION OF ANTIFIBRINOLYTIC AGENT POTENTIATE THE ACTION OF BACILLUS CALMETTE- GUERIN AFTER TRANSURETHRAL RESECTION OF NON–MUSCLE INVASIVE BLADDER CANCER?: MULTICENTER PROSPECTIVE RANDOMIZED CONTROLLED STUDY. [PDF]
Mohamed A. R. Soliman+6 more
openalex +1 more source
Alterações da coagulação associadas à leucemia promielocítica aguda [PDF]
Acute promyelocytic leukemia is frequently accompanied by coagulation abnormalities usually described as laboratorial disseminated intravascular coagulation, which is the main cause of morbidity and early mortality. Aberrant activation of the coagulation
JACOMO, Rafael H., REGO, Eduardo M.
core +2 more sources
Oral nimodipine reduces prostaglandin and thromboxane production by arteries chronically exposed to a periarterial haematoma and the antifibrinolytic agent tranexamic acid. [PDF]
John D. Pickard+5 more
openalex +1 more source
Antifibrinolytic agents for ruptured intracranial aneurysms. [PDF]
Joris van Rossum, Axel R. Wintzen
openalex +3 more sources
Natural and synthetic antifibrinolytics: Inert, poisonous or therapeutic agents? [PDF]
Jean‐François Hardy, Sylvain Bélisle
openalex +1 more source
Plenary Abstracts Session & Oral Presentations
HemaSphere, Volume 9, Issue S1, June 2025.
wiley +1 more source